Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Viemed Healthcare Community
NasdaqCM:VMD Community
3
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Community Investing Ideas
Viemed Healthcare
Popular
Undervalued
Overvalued
Viemed Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding In-Home Clinical Services Will Unlock Opportunities In Respiratory And Mental Health Markets
Key Takeaways Viemed's expansion into underserved respiratory care and home-based healthcare aligns with market trends, potentially boosting revenue and improving margins. Strong financial health and no net debt position Viemed for strategic acquisitions, enhancing growth and long-term stability.
View narrative
US$13.00
FV
45.4% undervalued
intrinsic discount
12.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
Updated
narrative
Viemed Healthcare
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Medicare And Telehealth Pressures Will Dampen Prospects Yet Spur Resilience
Key Takeaways Heavy dependence on government payors and industry consolidation may cap revenue growth and squeeze margins through reimbursement cuts and increased bargaining power against Viemed. Limited technological investment and product concentration could expose Viemed to disruption from more advanced competitors and evolving care models, threatening long-term growth.
View narrative
US$11.00
FV
35.5% undervalued
intrinsic discount
12.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
Viemed Healthcare
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging US Population And Respiratory Trends Will Expand Home Care
Key Takeaways Expanding demand for in-home respiratory care and strategic geographic growth position the company to capture a larger, profitable market. Technology investments and an asset-light model support higher margins, strong cash flow, and provide flexibility for future acquisitions.
View narrative
US$12.50
FV
43.2% undervalued
intrinsic discount
12.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
Your Valuation for
VMD
VMD
Viemed Healthcare
Your Fair Value
US$
Current Price
US$7.10
19.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
411m
2015
2018
2021
2024
2025
2027
2030
Revenue US$411.1m
Earnings US$23.8m
Advanced
Set Fair Value